Galapagos Genomics NV, Mechelen, Belgium, and Degussa BioActives, Champaign, IL, have entered into a research collaboration to identify nutraceuticals beneficial in joint health management. Under the agreement, Galapagos will design human cellular assays measuring key biological processes. This includes assay development, screening of libraries of natural compounds and validation of identified leads with focus on the field of arthritis. Degussa has exclusive rights to commercialize nutraceuticals that result from this research collaboration.